Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5898)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2013 (publication date) through Jul 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Xu JM, Wang Y, Ge FJ, Lin L, Liu ZY, Sharma MR. Severe irinotecan-induced toxicity in a patient with |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i24/3899.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
CHIHARU UEKURI, HIROSHI SHIGETOMI, SUMIRE ONO, YOSHIKAZU SASAKI, MIYUKI MATSUURA, HIROSHI KOBAYASHI. Toward an understanding of the pathophysiology of clear cell carcinoma of the ovary (Review). Oncology Letters 2013; 6(5): 1163 doi: 10.3892/ol.2013.1550
|
| 3 |
Zi-zhao Yang, Li Li, Lu Wang, Ling-min Yuan, Ming-cheng Xu, Jing-kai Gu, Hui-di Jiang, Lu-shan Yu, Su Zeng. The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants. Acta Pharmacologica Sinica 2017; 38(8): 1184 doi: 10.1038/aps.2016.157
|
| 4 |
|
| 5 |
Lang Yi, Guigao Lin, Kuo Zhang, Lunan Wang, Rui Zhang, Jiehong Xie, Jinming Li, Valli De Re. Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China. PLOS ONE 2016; 11(1): e0148081 doi: 10.1371/journal.pone.0148081
|
| 6 |
Chalirmporn Atasilp, Phichai Chansriwong, Ekaphop Sirachainan, Thanyanan Reungwetwattana, Suwannee Sirilerttrakul, Monpat Chamnanphon, Apichaya Puangpetch, Chonlaphat Sukasem. Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-70351-0
|
| 7 |
Dimitar Hristovski, Andrej Kastrin, Dejan Dinevski, Anita Burgun, Lovro Žiberna, Thomas C. Rindflesch. Using Literature-Based Discovery to Explain Adverse Drug Effects. Journal of Medical Systems 2016; 40(8) doi: 10.1007/s10916-016-0544-z
|
| 8 |
Xianghong Lai, Anmei Wang, Weiguo Li. Clinical Study on Prevention of Irinotecan-Induced Delayed-Onset Diarrhea by Hot Ironing with Moxa Salt Packet on Tianshu and Shangjuxu. Emergency Medicine International 2022; 2022: 1 doi: 10.1155/2022/6587884
|
| 9 |
XiaoXia Wei, JiaQin Cai, Hong Sun, Na Li, Chenxia Xu, Guifeng Zhang, Yuxia Sui, Jie Zhuang, Bin Zheng.
Cost–Effectiveness Analysis of
UGT1A1*6/*28
Genotyping for Preventing FOLFIRI-Induced Severe Neutropenia in Chinese Colorectal Cancer Patients
. Pharmacogenomics 2019; 20(4): 241 doi: 10.2217/pgs-2018-0138
|
| 10 |
Fuping Gao, Qing Yuan, Liang Gao, Pengju Cai, Huarui Zhu, Ru Liu, Yaling Wang, Yueteng Wei, Guodong Huang, Jian Liang, Xueyun Gao. Cytotoxicity and therapeutic effect of irinotecan combined with selenium nanoparticles. Biomaterials 2014; 35(31): 8854 doi: 10.1016/j.biomaterials.2014.07.004
|
| 11 |
Chonlaphat Sukasem, Chalirmporn Atasilp, Pichai Chansriwong, Montri Chamnanphon, Apichaya Puangpetch, Ekapob Sirachainan. Development of Pyrosequencing Method for Detection of UGT1A1 Polymorphisms in Thai Colorectal Cancers. Journal of Clinical Laboratory Analysis 2016; 30(1): 84 doi: 10.1002/jcla.21820
|
| 12 |
Lauren Walker, Vincent Yip, Munir Pirmohamed. Handbook of Pharmacogenomics and Stratified Medicine. 2014; : 405 doi: 10.1016/B978-0-12-386882-4.00020-7
|
| 13 |
Manzhao Ouyang, Zhentao Luo, Weijie Zhang, Dajian Zhu, Yan Lu, Jinhao Wu, Xueqing Yao. Protective effect of curcumin against irinotecan‑induced intestinal mucosal injury via attenuation of NF‑κB activation, oxidative stress and endoplasmic reticulum stress. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4714
|
| 14 |
L. Faugeras, A. Dili, A. Druez, B. Krug, C. Decoster, L. D’Hondt. Treatment options for metastatic colorectal cancer in patients with liver dysfunction due to malignancy. Critical Reviews in Oncology/Hematology 2017; 115: 59 doi: 10.1016/j.critrevonc.2017.03.029
|
| 15 |
Qian-Qian Yu, Hong Qiu, Ming-Sheng Zhang, Guang-Yuan Hu, Bo Liu, Liu Huang, Xin Liao, Qian-Xia Li, Zhi-Huan Li, Xiang-Lin Yuan. Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy. World Journal of Gastroenterology 2016; 22(16): 4250-4258 doi: 10.3748/wjg.v22.i16.4250
|